[Rheumatology on the move].
Dörner
T
T
Siegenthaler
W
W
Burmester
G R
GR
D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000628:therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005858:Germany; D014890:Granulomatosis with Polyangiitis / Q000628:therapy; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D012216:Rheumatic Diseases / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000628:therapy*; D012219:Rheumatology / Q000639:trends*; D012795:Sialoglycoproteins / Q000627:therapeutic use; D012955:Societies, Medical; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014463:Ultrasonography
D018501:Antirheumatic Agents; C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D012795:Sialoglycoproteins; D014409:Tumor Necrosis Factor-alpha; D003520:Cyclophosphamide